Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.352,64
0,03%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Centogene NV (CNTG) Centogene NV (CNTG) Notizie

CNTG

Centogene NV (CNTG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNTG
DataOraFonteTitoloSimboloCompagnia
31/05/202422:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
31/05/202422:30GlobeNewswire Inc.CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General MeetingNASDAQ:CNTGCentogene NV
17/05/202413:20Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NASDAQ:CNTGCentogene NV
15/05/202423:17GlobeNewswire Inc.CENTOGENE Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CNTGCentogene NV
15/05/202423:12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:CNTGCentogene NV
15/05/202423:10GlobeNewswire Inc.CENTOGENE Secures Approx. $20 Million to Strengthen Cash PositionNASDAQ:CNTGCentogene NV
14/05/202414:30GlobeNewswire Inc.CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseNASDAQ:CNTGCentogene NV
10/05/202412:30GlobeNewswire Inc.CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsNASDAQ:CNTGCentogene NV
02/04/202422:30GlobeNewswire Inc.CENTOGENE Receives Nasdaq Non-Compliance NoticeNASDAQ:CNTGCentogene NV
19/03/202411:30GlobeNewswire Inc.CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersNASDAQ:CNTGCentogene NV
29/02/202423:00GlobeNewswire Inc.CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα DeficiencyNASDAQ:CNTGCentogene NV
28/02/202412:30GlobeNewswire Inc.CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingNASDAQ:CNTGCentogene NV
28/02/202412:30GlobeNewswire Inc.CENTOGENE Explores Strategic AlternativesNASDAQ:CNTGCentogene NV
25/01/202412:30GlobeNewswire Inc.CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationNASDAQ:CNTGCentogene NV
24/01/202412:30GlobeNewswire Inc.CENTOGENE Receives French Research Tax Credit AccreditationNASDAQ:CNTGCentogene NV
23/01/202412:30GlobeNewswire Inc.CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using MultiomicsNASDAQ:CNTGCentogene NV
18/01/202412:30GlobeNewswire Inc.CENTOGENE Announces Preliminary Full Year 2023 RevenueNASDAQ:CNTGCentogene NV
19/12/202312:30GlobeNewswire Inc.CENTOGENE Announces Voting Results of Extraordinary General MeetingNASDAQ:CNTGCentogene NV
13/12/202312:30GlobeNewswire Inc.CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment MilestoneNASDAQ:CNTGCentogene NV
28/11/202312:30GlobeNewswire Inc.CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture TransactionNASDAQ:CNTGCentogene NV
14/11/202314:30GlobeNewswire Inc.CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and ParkinsonismNASDAQ:CNTGCentogene NV
10/10/202312:30GlobeNewswire Inc.CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic OfferingNASDAQ:CNTGCentogene NV
11/09/202314:30GlobeNewswire Inc.CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:CNTGCentogene NV
07/09/202323:00GlobeNewswire Inc.CENTOGENE Reports First Half 2023 Financial ResultsNASDAQ:CNTGCentogene NV
01/09/202314:00GlobeNewswire Inc.CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease PatientsNASDAQ:CNTGCentogene NV
31/08/202322:30GlobeNewswire Inc.CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencyNASDAQ:CNTGCentogene NV
07/08/202312:30GlobeNewswire Inc.CENTOGENE to Participate in Upcoming Conferences in AugustNASDAQ:CNTGCentogene NV
14/07/202312:30GlobeNewswire Inc.CENTOGENE Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CNTGCentogene NV
12/07/202313:30GlobeNewswire Inc.CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease CohortNASDAQ:CNTGCentogene NV
02/07/202311:00PR Newswire (US)Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic TestingNASDAQ:CNTGCentogene NV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNTG

La tua Cronologia

LSE
61HY
Hsbc Bk.30
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network